Ovid Therapeutics's total assets for Q3 2024 were $102.65M, a decrease of -13.07% from the previous quarter. OVID total liabilities were $26.36M for the fiscal quarter, a -9.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.